A human monoclonal antibody against the distal carboxyl terminus of ADAMTS‐13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura
Konstantine Halkidis, Don L. Siegel, X. Long Zheng
Topics & Concepts
ADAMTSMonoclonal antibodyThrombotic thrombocytopenic purpuraAutoantibodyThrombospondinThrombotic microangiopathyADAMTS13AntibodyChemistryDisintegrinMonoclonalMetalloproteinaseRecombinant DNAMolecular biologyBiochemistryMedicineMatrix metalloproteinaseImmunologyPlateletBiologyInternal medicineGeneDiseaseComplement system in diseasesMonoclonal and Polyclonal Antibodies ResearchHemophilia Treatment and Research